Dr. Tong Wu

Dr. Tong Wu received her Ph.D. in molecular genetics from Chinese Academy of Sciences. She then worked at Georgia State University (Atlanta, USA) and Ottawa Hospital (Ottawa, Canada) as a post-doctoral fellow. Her research included the development of DNA vaccines and novel vaccine adjuvants. Dr. Wu joined the Vaccine Quality Division 3 of Health Canada as a Senior Scientific Evaluator in 2005, and currently is the division manager. Since joining Health Canada, Dr. Wu has led the quality review of many complex vaccine submissions and contributed to the risk-benefit based regulatory decisions. She has developed broad expertise in manufacturing and control of vaccines, as well as the development of analytical methods and the application of correlates of protection for clinical assessment of vaccines. Since 2007, Dr. Wu has served as a WHO Temporary Adviser to support WHO in activities related to vaccines, such as preparation of WHO Guidelines as a key drafting group member, dossier review for the pre-qualification program, and presentation at workshops for the implementation of WHO guidelines.